Starting Xeljanz (Tofacitinib): What to Expect on Your Treatment Journey
Being prescribed Xeljanz (tofacitinib) for rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, or ankylosing spondylitis raises a lot of practical questions that go beyond the prescription itself. How soon will you feel a difference? What does daily life on a JAK inhibitor actually look like? What testing will your care team order, and why? This guide walks through the Xeljanz treatment journey step by step, from the first dose through long-term monitoring, so you know what to expect at each stage.
If your main concern right now is affording your prescription, we cover that separately: see our Xeljanz costs and generic availability FAQ for pricing and generic questions, or our Xeljanz copay assistance page to start saving. This article focuses on what the treatment experience itself is like.
Before You Start: Getting Ready for Xeljanz
Xeljanz therapy begins before your first dose. Because tofacitinib affects how your immune system functions, your care team completes several baseline steps to make sure it is safe for you to start.
Your prescriber will typically screen for tuberculosis and viral hepatitis (both B and C), check baseline bloodwork including lymphocyte count, neutrophil count, and hemoglobin, and review your vaccination history. Live vaccines should be brought up to date before you begin, because they are not given during treatment. Therapy is generally not started if your absolute lymphocyte count is below 500 cells/mm3, your ANC is below 1,000 cells/mm3, or your hemoglobin is below 9 g/dL.
This preparation phase is normal and protective. It is the same careful groundwork your rheumatologist or gastroenterologist lays for any advanced immune-modulating therapy.
How Long Does Xeljanz Take to Work?
One of the most common questions patients ask is how quickly they will notice a change. The honest answer is that it varies by condition and by person.
For rheumatoid arthritis and psoriatic arthritis, some people begin to notice reduced joint pain and stiffness within about two weeks, though it can take up to three to four months to feel the full effect. For ulcerative colitis, many patients see symptom improvement within two to eight weeks of starting induction therapy. Response times are individual, and your care team will assess how well the medication is working over a series of follow-up visits rather than from a single early checkpoint.
It helps to think of the first few months as a ramp, not a switch. Keeping a simple symptom log (joint stiffness in the morning, number of flares, energy levels, or bowel symptoms depending on your condition) gives your prescriber useful information at each visit.
Xeljanz vs Xeljanz XR: What the Difference Means for Daily Life
Tofacitinib comes in more than one form, and which one you take changes your daily routine.
Xeljanz immediate-release (IR) is taken twice daily and is available as 5 mg and 10 mg tablets, plus a 1 mg/mL oral solution for patients who need a liquid form. Xeljanz XR is the extended-release version, taken once daily, available as 11 mg and 22 mg tablets.
The practical trade-off is routine versus simplicity. The IR tablet means remembering two doses a day; the XR tablet means one. The two are not interchangeable on a milligram-for-milligram basis, so never switch between them on your own. Your prescriber decides which formulation fits your condition and lifestyle, and if you transition from IR to XR, the XR dose begins the day after your last IR dose.
One quirk worth knowing: with Xeljanz XR, you may occasionally notice the empty tablet shell in your stool. This is completely normal. The medication has already been absorbed; what you are seeing is the inert shell that delivered it. The XR tablet must always be swallowed whole, never crushed, split, or chewed.
What the Monitoring Schedule Looks Like
Ongoing lab monitoring is a defining part of life on tofacitinib, and knowing the rhythm ahead of time makes it feel far less daunting. Your care team uses regular bloodwork to keep therapy both safe and effective.
A typical monitoring rhythm includes lymphocyte count at the start and every three months, neutrophil and platelet counts at baseline, again after four to eight weeks, and then every three months, and hemoglobin on the same schedule. Lipids (including LDL and HDL cholesterol) are checked roughly four to eight weeks after you begin and periodically after that, since tofacitinib can raise cholesterol levels. Liver function is checked at baseline and periodically. Your prescriber will also keep an eye on blood pressure and watch for any signs of infection at your visits.
If certain lab values fall outside safe thresholds, your prescriber may pause or adjust your dose. This is a routine part of managing the medication well, not a sign that something has gone wrong. Keeping your lab appointments is one of the most important things you can do for a smooth treatment journey.
Side Effects: What Is Common and What to Watch For
Knowing which side effects are common and expected, versus which ones need prompt attention, helps you respond calmly and appropriately.
More common, generally manageable effects include upper respiratory infections and nasopharyngitis (cold-like symptoms), headache, diarrhea, and raised cholesterol levels picked up on routine labs. Your care team monitors these and helps you manage them.
Some effects deserve prompt attention. Tofacitinib carries a US Boxed Warning, the FDA’s most serious warning, covering serious infections, increased mortality risk in certain older RA patients with cardiovascular risk factors, malignancies, major adverse cardiovascular events, and blood clots. In everyday terms, that means you should contact your healthcare provider promptly if you develop signs of infection (fever, persistent cough, night sweats), chest pain or shortness of breath, swelling or pain in a leg, unusual skin changes, or severe abdominal pain. Shingles (herpes zoster) is also somewhat more common on tofacitinib, so report a new painful rash quickly.
Living Well on Xeljanz Day to Day
Beyond doses and labs, a few habits make the treatment journey smoother.
Take tofacitinib consistently, with or without food, at the times your prescriber recommends. Keep all medications, supplements, and herbal products on a single list and share it with every provider you see, since tofacitinib interacts with certain drugs (including strong CYP3A4 inhibitors and inducers) and should not be combined with biologic DMARDs or potent immunosuppressants. Avoid live vaccines during treatment, and plan any non-live vaccines with your care team. Mention any planned surgery well in advance, since tofacitinib is typically held for a few days before elective major procedures.
Store your tablets and oral solution at room temperature, and keep them out of reach of children and pets. If you use the oral solution, discard it 60 days after first opening the bottle.
Most importantly, do not stop or pause therapy on your own, even if you feel better or hit a rough patch. If cost, side effects, or access ever make you consider skipping doses, call your care team or pharmacist first. There are almost always options that let you stay on track.
How QuickRx Supports You Through Treatment
QuickRx Specialty Pharmacy is a nationwide specialty pharmacy licensed in all 50 states, and our support goes well beyond filling your prescription. Our pharmacists are available to answer questions about side effects, drug interactions, and administration, our team coordinates refills and home delivery so you never face a gap in therapy, and our patient navigators handle prior authorizations and benefits coordination on your behalf.
If you have a clinical question about your Xeljanz treatment, or you simply want a pharmacist to walk you through what to expect, call us at (917) 830-2525. For questions specifically about cost, generic tofacitinib, or copay assistance, our Xeljanz FAQ and copay assistance page are the best places to start.
Frequently Asked Questions
It depends on your condition. For rheumatoid arthritis and psoriatic arthritis, some people notice less joint pain and stiffness within about two weeks, with the full effect taking up to three to four months. For ulcerative colitis, many patients improve within two to eight weeks of starting induction therapy. Everyone responds differently, so your prescriber evaluates your progress across several visits rather than from one early checkpoint.
Xeljanz immediate-release (IR) is taken twice daily and comes as 5 mg and 10 mg tablets and a 1 mg/mL oral solution. Xeljanz XR is extended-release, taken once daily, as 11 mg and 22 mg tablets. The two are not interchangeable milligram-for-milligram, so your prescriber determines which is right for you, and you should never switch between them on your own.
This is normal and expected with the extended-release formulation. The medication has already been absorbed by your body; what appears in the stool is the inert shell that delivered the dose. It does not mean the medication failed to work. Always swallow Xeljanz XR whole, never crushed, split, or chewed.
Your care team uses regular bloodwork to keep therapy safe and effective. This typically includes lymphocyte, neutrophil, platelet, and hemoglobin counts on a schedule (baseline, around four to eight weeks, then every three months), cholesterol checks a few weeks after starting and periodically after, and liver function tests. Your prescriber also monitors blood pressure and watches for signs of infection. Keeping your lab appointments is one of the most important parts of a smooth treatment journey.
Yes. Xeljanz can be taken with or without food. The only special instruction is for Xeljanz XR extended-release tablets, which must be swallowed whole and never crushed, split, or chewed.
Do not stop or pause therapy on your own. If side effects, cost, or access make you think about skipping doses, call your care team or pharmacist first. There are usually options that let you stay on therapy safely. You can reach a QuickRx pharmacist at (917) 830-2525.
Educational Resources
Learn more about tofacitinib and the conditions it treats from these trusted sources:
- FDA, Xeljanz Prescribing Information
- MedlinePlus, Tofacitinib
- NIH / NIAMS, Rheumatoid Arthritis
- Crohn’s & Colitis Foundation
Reviewed by: Julia Kravtsova, PharmD, Head Patient Navigator, QuickRx Specialty Pharmacy
Last Updated: June 2026
